The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD

Depression and Anxiety

Volumn 30, Issue 2, 2013, Pages 93-96

  Neumeister, Alexander ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CALCIUM; CANNABINOID 1 RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOCANNABINOID; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; NORADRENALIN; SEX HORMONE;

AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; CALCIUM CELL LEVEL; CHRONIC STRESS; CONDITIONING; DISEASE COURSE; EVIDENCE BASED MEDICINE; FEAR; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IRRITABILITY; MEMORY; MEMORY CONSOLIDATION; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REINFORCEMENT; SECONDARY PREVENTION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SLEEP DISORDER; VENTROMEDIAL PREFRONTAL CORTEX;

DRUG DISCOVERY; ENDOCANNABINOIDS; EXTINCTION, PSYCHOLOGICAL; HUMANS; MEMORY; RECEPTORS, CANNABINOID; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL;

EID: 84872929841     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22031     Document Type: Article

References (24)

1. Stein DJ, Ipser JC, Seedat S,. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2006; 25 (1): CD002795.
2. Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry 2007; 68 (5): 711-720. (Pubitemid 46841854)
3. Berger W, Mendlowicz MV, Marques-Portella C, et al. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33 (2): 169-180.
4. Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA 2011; 306 (5): 493-502.
5. Phelps EA, LeDoux JE,. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005; 48 (2): 175-187. (Pubitemid 41476352)
6. Rauch SL, Shin LM, Phelps EA,. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research-past, present, and future. Biol Psychiatry 2006; 60 (4): 376-382. (Pubitemid 44215857)
7. Hill MN, Patel S, Carrier EJ, et al. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 2005; 30 (3): 508-515. (Pubitemid 40271153)
8. Hill MN, Miller GE, Ho WS, et al. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry 2008; 41 (2): 48-53. (Pubitemid 351427522)
9. Vetter S, Rossegger A, Rossler W, et al. Exposure to the tsunami disaster, PTSD symptoms and increased substance use-an Internet based survey of male and female residents of Switzerland. BMC Public Health 2008; 19(8): 92.
10. Cornelius JR, Kirisci L, Reynolds M, et al. PTSD contributes to teen and young adult cannabis use disorders. Addict Behav 2010; 35 (2): 91-94.
11. Hirvonen J, Goodwin RS, Li CT, et al. Reversible and regionally selective downregulation of brain cannabinoid CB(1) receptors in chronic daily cannabis smokers. Mol Psychiatry 2012; 17 (6): 642-649.
12. Leweke FM, Koethe D,. Cannabis and psychiatric disorders: it is not only addiction. Addict Biol 2008; 13 (2): 264-275. (Pubitemid 351692982)
13. Bambico FR, Nguyen NT, Katz N, Gobbi G,. Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiol Dis 2010; 37 (3): 641-655.
14. Klugmann M, Klippenstein V, Leweke FM, et al. Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels. Int J Neuropsychopharmacol 2011; 14 (4): 505-517.
15. Suarez J, Llorente R, Romero-Zerbo SY, et al. Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. Hippocampus 2009; 19 (7): 623-632.
16. Piomelli D,. The endocannabinoid system: a drug discovery perspective. Curr Opin Investig Drugs 2005; 6 (7): 672-679. (Pubitemid 40904037)
17. Roozendaal B, McGaugh JL,. Memory modulation. Behav Neurosci 2011; 125 (6): 797-824.
18. Roozendaal B, Barsegyan A, Lee S,. Adrenal stress hormones, amygdala activation, and memory for emotionally arousing experiences. Prog Brain Res 2008; 167: 79-97. (Pubitemid 350123226)
19. Atsak P, Roozendaal B, Campolongo P,. Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience 2012; 204: 104-116.
20. Campolongo P, Roozendaal B, Trezza V, et al. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci USA 2009; 106 (12): 4888-4893.
21. Hill MN, McEwen BS,. Endocannabinoids: the silent partner of glucocorticoids in the synapse. Proc Natl Acad Sci USA 2009; 106 (12): 4579-4580.
22. Dlugos A, Childs E, Stuhr KL, et al. Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology 2012; 37 (11): 2416-2427.
23. Hill MN, Miller GE, Carrier EJ, et al. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 2009; 34 (8): 1257-1262.
24. Fattore L, Fratta W,. How important are sex differences in cannabinoid action? Br J Pharmacol 2010; 160 (3): 544-548.